Early and late posttransplant lymphoproliferative disorder after lung transplantation--34 cases from the European PTLD Network.

ow naded rom http:urnals.lw w om /transtjournalby hD M fePH bH 4TIm qVAH xkFJpPk1L/H vM G w qM xG jw O deJPG +b4D lKuA44qu/vw zm c= on 079/2018 Downloadedfromhttp://journals.lww.com/transplantjournalbyBhDMf5ePHKbH4TTImqenVAHxkFJp/XpPk1L/H3vMGwqMxG9jwOd8eJPG+b4DlKuAX44qu/vwzmc=on07/29/2018 5. Perez K, Castillo J, Dezube BJet al.Human immunodeficiency virus-associated anaplastic large cell lymphoma. Leuk Lymphoma 2010; 51: 430. 6. Balachandran I, Walker JW Jr, Broman J. Fine needle aspiration cytology of ALK1(-), CD30+ anaplastic large cell lymphoma post renal transplantation: a case report and literature review. Diagn Cytopathol 2010; 38:213. 7. Gopal AK, Ramchandren R, O’Connor OA, et al. Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation. Blood 2012; 120: 560. 8. Younes A, Bartlett NL, Leonard JP, et al. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med 2010; 363: 1812. 9. Galand C, Donnou S, Crozet L, et al. Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma. PLoS One 2011; 6: e24622. 10. Kesselring R, Thiel A, Pries R, et al. The number of CD161 positive Th17 cells are decreased in head and neck cancer patients. Cell Immunol 2011; 269: 74.

[1]  P. Jaksch,et al.  Effect of Cytomegalovirus Immunoglobulin on the Incidence of Lymphoproliferative Disease After Lung Transplantation: Single-Center Experience With 1157 Patients , 2013, Transplantation.

[2]  Scott E. Smith,et al.  Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation. , 2012, Blood.

[3]  J. Zaucha,et al.  Interim analysis of the largest prospective trial to date in adult CD20-positive post-transplant lymphoproliferative disorder (PTLD): Introducing risk-stratified sequential treatment (RSST). , 2012 .

[4]  G. Salles,et al.  Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. , 2012, The Lancet. Oncology.

[5]  C. Sautès-Fridman,et al.  Th17 Cells Are Involved in the Local Control of Tumor Progression in Primary Intraocular Lymphoma , 2011, PloS one.

[6]  A. Pavie,et al.  Adapted Management of EBV Reactivation After Solid Organ Transplantation: An Effective Prevention of Post Transplantation Lymphoproliferative Disorders (PTLD). Results of the Largest Prospective Study on 251 Patients , 2010 .

[7]  I. Balachandran,et al.  Fine needle aspiration cytology of ALK 1(−), CD 30(+) anaplastic large cell lymphoma post renal transplantation: A case report and literature review , 2009, Diagnostic cytopathology.

[8]  H. Fickenscher,et al.  Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis. , 2007, The Lancet. Oncology.

[9]  H. Heslop,et al.  Quantitative EBV Viral Loads and Immunosuppression Alterations can Decrease PTLD Incidence in Pediatric Liver Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.